Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2004
Allegations concerning marketing incentives and physician payments
Schering-Plough was accused of using marketing gimmicks and payments to doctors to encourage prescriptions of company products. The allegations contributed to scrutiny of pharmaceutical promotional practices.
2002
Albuterol inhaler manufacturing consent decree
Schering-Plough entered a consent decree with the FDA after manufacturing issues involving its albuterol inhaler. The company was ordered to pay $500 million to the U.S. Treasury, according to the referenced account.